Smoking Cessation
📧 Sign up to get email alerts when something new happens for Smoking Cessation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: A Focus Group Study to Explore Smoking Triggers and Acceptability of Just-in-time Adaptive Intervent
A completed focus group study from University of Colorado Denver examining smoking triggers and the acceptability of a just-in-time adaptive…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Urban and Reservation Implementation of All Nations Breath of Life [NA]
Lehigh University is conducting a clinical trial to study urban and reservation implementation of All Nations Breath of Life for smoking ces…
-
FDA approval · 2025-01-29FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Bupropion hydrochloride by Alembic Pharmaceuticals Limited under the ANDA pathway, authorizing t…
-
FDA approval · 2024-12-09FDA Approved: VARENICLINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original application for varenicline as a generic version for smoking cessation.
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Varenicline for Treatment of E-cigarette Dependence [Phase 2]
Phase 2 trial results for varenicline in treating e-cigarette dependence have been posted; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-11-21FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Nicorette (nicotine polacrilex) submitted by Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Deep rTMS and Varenicline for Smoking Cessation [NA]
The clinical trial evaluating deep rTMS in combination with varenicline for smoking cessation has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Varenicline OTC Trial on Efficacy and Safety [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of an over-the-counter varenicline formulation for tobacco use disorder, wi…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies
This clinical trial aims to unravel the genetic basis of nicotine addiction to guide the development of new therapeutic strategies and is cu…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Combining Default Choices and a Decision Aid to Improve Tobacco Cessation [NA]
This clinical trial update reports on a study investigating whether default choices plus a decision aid can improve smoking cessation outcom…
-
FDA approval · 2024-05-07FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Bupropion hydrochloride from Micro Labs Limited under ANDA207403, signaling regulatory approval …
-
FDA approval · 2024-04-30FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) submitted by Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: A First-in-Human Study of SBP-9330 in Healthy Subjects [Phase 1]
First-in-human Phase 1 study of SBP-9330 in healthy subjects for smoking cessation completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers [NA]
A completed clinical trial focused on implementing lung screening and smoking cessation treatment in community health centers, with results …
-
CLINICAL_TRIALS trial_result · 2024-04-01Clinical Trial Update: Randomized Pilot Study of a mHealth App for Ambivalent Smokers Living With HIV [NA]
A randomized pilot study evaluated a mobile health app for ambivalent smokers living with HIV; results posted after completion.
-
FDA approval · 2024-03-15FDA Approved: DG HEALTH NICOTINE — Supplemental Application (Dolgencorp Inc)
The FDA approved a supplemental application for DG Health Nicotine (nicotine polacrilex) submitted by Dolgencorp Inc, updating regulatory st…
-
FDA approval · 2024-03-15FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for EQUATE NICOTINE (nicotine polacrilex) by Wal-Mart Stores Inc, approving a store-brand nicotine r…
-
FDA approval · 2024-03-15FDA Approved: GOOD NEIGHBOR PHARMACY NICOTINE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Nicotine (nicotine polacrilex) under ANDA076789, representing an approved…
-
FDA approval · 2024-03-15FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Nicotine (nicotine polacrilex) from Wal-Mart Stores Inc, confirming its use as a nicotine…
-
FDA approval · 2024-03-15FDA Approved: BASIC CARE NICOTINE — Supplemental Application (Amazon.com Services LLC)
FDA approved a supplemental application for BASIC CARE NICOTINE (nicotine polacrilex) submitted by Amazon.com Services LLC.
-
FDA approval · 2024-03-15FDA Approved: NICOTINE — Supplemental Application (H E B)
FDA approves a supplemental application for NICOTINE (nicotine polacrilex) from H E B, indicating an updated label or additional use for thi…
-
FDA approval · 2024-03-06FDA Approved: VARENICLINE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved Marlex Pharmaceuticals' original application for varenicline tartrate, a smoking cessation aid.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO) [Phase 2]
Phase 2 trial update on COMBO (varenicline + oral nicotine replacement therapy) for smoking cessation; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Message Testing in Older Adult Smokers [NA]
A completed clinical trial evaluating message testing in older adult smokers; results posted in 2024.
-
FDA approval · 2024-01-03FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC. This action represents reg…